ScoliCare

Diving into costs from Item 7, ScoliCare's initial investment spans $161,800-$541,500, covering $49,000 franchise fee, clinic buildout, equipment like the proprietary ScoliBrace, and initial marketing. Ongoing fees include 5% royalty (or annual minimum, whichever greater), 4.5% brand/ad fund, plus $700-$800 monthly tech fee—positioning total fees around 9.5-10% plus fixed costs. Item 19 shines brightly: average gross revenue $889,959, median $698,633 across 4 units, suggesting top performers drive averages high while medians indicate solid baseline for mature clinics. No profit figures disclosed, but these grosses imply strong margins in a service-heavy model post-ramp-up, especially targeting underserved scoliosis patients.

System health per Items 20/21 shows cautious growth: 3 locations in 2024 to 4 in 2025 (+33%), with zero terminations, transfers, or renewals in recent years due to youth—no contractions signal stability. Projections in Item 20 anticipate modest openings, fitting a high-touch medical franchise needing qualified pros. For investors, the revenue punch per unit stands out versus investment scale, but tiny footprint raises validation risks—high grosses may reflect outliers in premium markets like Australia/NZ hubs. Weigh if your expertise in health services justifies the upper-end buildout in this specialized play.